Company Filing History:
Years Active: 2017
Title: Kebing Yu: Innovator in USP7 Inhibitor Compounds
Introduction
Kebing Yu is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of USP7 inhibitor compounds. His work focuses on innovative methods for treating cancer and immune disorders.
Latest Patents
Kebing Yu holds a patent for USP7 inhibitor compounds and methods of use. The patent describes 2-Aminopyridine compounds of Formula I, which include various substituents such as stereoisomers, tautomers, and pharmaceutically acceptable salts. These compounds are useful for modulating USP7 and for treating conditions like cancer and inflammation mediated by USP7. The patent also discloses methods for using these compounds in vitro, in situ, and in vivo for diagnosis and treatment of related disorders in mammalian cells.
Career Highlights
Throughout his career, Kebing Yu has worked with prominent companies in the pharmaceutical industry. He has been associated with Genentech, Inc. and F. Hoffmann-La Roche AG, where he has contributed to various research and development projects. His expertise in the field has led to advancements in therapeutic strategies.
Collaborations
Kebing Yu has collaborated with esteemed colleagues, including Robert Anthony Blake and Paola Di Lello. These partnerships have fostered innovation and have been instrumental in the development of his patented compounds.
Conclusion
Kebing Yu is a distinguished inventor whose work on USP7 inhibitor compounds has the potential to impact the treatment of cancer and immune disorders significantly. His contributions to the pharmaceutical industry highlight the importance of innovation in addressing complex health challenges.